Showing results (851-860 of 2,106) with videos related to
Sort By:
Pageof 211
CNS Drugs|September 11, 2013
Extended-release intramuscular naltrexone (VIVITROL®): a review of its use in the prevention of relapse to opioid dependence in detoxified patientsYahiya Y Syed, Gillian M KeatingCNS Drugs|August 21, 2013
Use of a structured medication history to establish medication use at admission to an old age psychiatric clinic: a prospective observational studyMeike C Prins, A Clara Drenth-van Maanen, Rob M Kok, et al.CNS Drugs|August 21, 2013
Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb studyRalf W Dittmann, Esther Cardo, Peter Nagy, et al.CNS Drugs|July 30, 2013
Health-related quality of life and functional outcomes from a randomized, controlled study of lisdexamfetamine dimesylate in children and adolescents with attention deficit hyperactivity disorderTobias Banaschewski, César Soutullo, Michel Lecendreux, et al.CNS Drugs|July 2, 2013
Efficacy and tolerability of perospirone in schizophrenia: a systematic review and meta-analysis of randomized controlled trialsTaro Kishi, Nakao IwataCNS Drugs|February 20, 2016
Potential of Oxytocin in the Treatment of SchizophreniaPaul D Shilling, David FeifelCNS Drugs|December 16, 2015
Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative DiseasesValeria Calsolaro, Paul EdisonCNS Drugs|November 16, 2013
Animal migraine models for drug development: status and future perspectivesInger Jansen-Olesen, Peer Tfelt-Hansen, Jes OlesenCNS Drugs|December 12, 2013
Drug repositioning: playing dirty to kill painLeandro Francisco Silva Bastos, Márcio Matos CoelhoPageof 211